Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation
Article 2020 en
Authors
AB
Anders Nissen Bonde
TM
Torben Martinussen
CL
Christina Ji‐Young Lee
Abstract
1 min read
Using instrumental variable estimation in a cohort of patients with AF, rivaroxaban was associated with higher risk of major bleeding compared with apixaban. No significant associations to other outcomes were found in main analyses.
Laila Stærk, Thomas Alexander Gerds, Professor Gregory Lip, Brice Ozenne, Anders Nissen Bonde, Morten Lamberts, Emil Loldrup Fosbøl, C. Torp‐Pedersen, Gunnar Gislason, Jonas Bjerring Olesen
Anders Nissen Bonde, Torben Martinussen, C Y Lee, Jayanta Bhattacharya, Professor Gregory Lip, Laila Stærk, Gunnar Gislason, Christian Torp‐Pedersen, Jonas Bjerring Olesen, Mark A. Hlatky
Discussion(0)
No comments yet. Be the first to comment.